Skip to main content
Smart Investors Daily
LA

AMEX · LABU

Direxion Daily S&P Biotech Bull 3X Shares

Financial Services · Asset Management

$191.71

Down-$0.95 (-0.49%)

Updated Nov 19, 2026, 6:25 AM

SID Score

4.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
919.27M
P/E ratio
—
Dividend yield
0.22%
52-week range
$133.96 – $341.93
Volume
297.27K
Avg. volume
936.23K

Price performance · LABU

LABU price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 18, 2026

LABU closed at $191.71 after 21 trading sessions, down 18.14% for the selected period.

Last close
$191.71
Period change
-18.14%
Period low
$191.71
Period high
$260.63
Daily close
View OHLC price history
LABU OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 18, 2026$190.79$201.86$188.70$191.71297.27K
Nov 17, 2026$200.19$202.1999$184.40$192.66296.86K
Nov 16, 2026$212.66$218.50$193.36$195.22408.93K
Nov 13, 2026$216.985$218.00$204.73$214.83342.56K
Nov 12, 2026$231.07$232.00$215.12$218.55488.56K
Nov 11, 2026$239.40$244.32$234.597$241.75211.69K
Nov 10, 2026$237.59$249.60$227.1705$236.32291.47K
Nov 9, 2026$229.175$249.055$218.3117$245.11376.57K
Nov 6, 2026$209.90$226.90$204.54$223.75310.07K
Nov 5, 2026$253.94$253.94$207.50$208.62640.37K
Nov 4, 2026$255.96$261.425$230.805$260.63416.4K
Nov 3, 2026$233.35$250.115$231.01$241.18210.78K
Nov 2, 2026$249.25$252.05$227.00$228.38274.58K
Oct 30, 2026$251.50$265.10$239.00$247.22303.07K
Oct 29, 2026$255.23$268.00$249.77$256.96399.19K
Oct 28, 2026$236.00$255.00$233.55$254.15396.76K
Oct 27, 2026$221.73$242.58$218.07$242.25316.21K
Oct 26, 2026$222.06$228.9999$218.80$223.49241.87K
Oct 23, 2026$222.63$224.50$210.635$219.60245.21K
Oct 22, 2026$230.21$241.2424$220.01$229.18364.68K
Oct 21, 2026$237.60$247.50$233.70$234.18314.51K

Latest LABU news

The latest Smart Investors Daily articles mentioning LABU.

LABU research

Overview

Company profile and research snapshot.

Company profile

The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.